Home/Filings/4/0001578563-23-000023
4//SEC Filing

Pavesio Alessandra 4

Accession 0001578563-23-000023

CIK 0001665988other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 5:05 PM ET

Size

7.7 KB

Accession

0001578563-23-000023

Insider Transaction Report

Form 4
Period: 2022-03-14
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
  • Award

    Restricted Stock Units

    2022-03-14+35,54535,545 total
    Class A Common Stock (35,545 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-03-14+96,13396,133 total
    Exercise: $1.16Exp: 2032-03-13Class A Common Stock (96,133 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  • [F2]The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001835185

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:05 PM ET
Size
7.7 KB